🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Durvalumab (Imfinzi) alone or in combination with platinum-based chemotherapy

Found 35 matching trials

Radiation Therapy in Unresectable Gall Bladder Cancer

PHASE2

The goal of this clinical trial is to compare two treatment regimes, namely...

Status

Recruiting

Location

Tata Memorial Centre

Start Date

2024-03-07

Trial ID

NCT06214572

Treatments Being Tested

Systemic therapy (Gemcitabine plus Cisplatin)RT Systemic therapy (Gemcitabine plus oxaliplatin)Systemic therapy (Gemcitabine plus Cisplatin plus Durvalumab)Systemic therapy (Gemcitabine plus cisplatin plus nab-paclitaxel)

Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).

PHASE3

This is a randomized, open-label, multi-center, global, Phase III study to ...

Status

Active Not Recruiting

Location

Research Site

Start Date

2017-06-01

Trial ID

NCT03164616

Treatments Being Tested

Durvalumab Tremelimumab Abraxane + carboplatin Gemcitabine + cisplatin Gemcitabine + carboplatin Pemetrexed + carboplatin Pemetrexed + cisplatin

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

PHASE2

In this study circulating tumor DNA (ctDNA) blood testing is used to detect...

Status

Suspended

Location

Stanford University

Start Date

2021-04-08

Trial ID

NCT04585477

Treatments Being Tested

AVENIO ctDNA Surveillance Kit Durvalumab Durvalumab (Imfinzi) alone or in combination with platinum-based chemotherapy

Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check)

PHASE2

This is an open label, randomized, Phase II multicenter study designed to e...

Status

Withdrawn

Location

Asklepios Fachkliniken München-Gauting

Start Date

2022-05-20

Trial ID

NCT05383001

Treatments Being Tested

combination regimen tremelimumab /durvalumab platinum-based chemotherapy (SoC)

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

PHASE1

This is a phase Ib/II, open-label multicentre study to assess the safety, t...

Status

Completed

Location

Research Site

Start Date

2018-02-07

Trial ID

NCT03421353

Treatments Being Tested

AZD9150 Durvalumab Cisplatin 5-Flourouracil Carboplatin Gemcitabine Nab-paclitaxel

A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy

PHASE2

A study to investigate efficacy and safety of ceralasertib plus durvalumab ...

Status

Active Not Recruiting

Location

Research Site

Start Date

2023-06-21

Trial ID

NCT05941897

Treatments Being Tested

Ceralasertib Durvalumab

Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer

PHASE3

Study to determine the safety and tolerability profile of durvalumab with p...

Status

Completed

Location

Research Site

Start Date

2021-11-11

Trial ID

NCT04774380

Treatments Being Tested

Durvalumab Cisplatin Carboplatin Etoposide

A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalumab With Olaparib as First-line Treatment in Advanced or Recurrent Endometrial Cancer in Spain

PHASE3

This is a phase IIIb, interventional, single arm, multicentre study assessi...

Status

Active Not Recruiting

Location

Research Site

Start Date

2024-12-30

Trial ID

NCT06746116

Treatments Being Tested

Durvalumab + Chemotherapy phase Durvalumab + Olaparib phase

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

PHASE2

The goal of this clinical trial is to test feasibility and safety of the co...

Status

Withdrawn

Location

Multiple Locations

Start Date

2024-12

Trial ID

NCT06017297

Treatments Being Tested

Durvalumab Tremelimumab Gemcitabine Cisplatin Surgical Resection

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

The purpose of this study is to evaluate the efficacy of radiotherapy as pa...

Status

Recruiting

Location

Center of Oncology of the Lublin Region St. Jana z Dukli in Lublin

Start Date

2024-04-01

Trial ID

NCT06529081

Treatments Being Tested

Palliative Radiotherapy Radical/Ablative Radiotherapy

Previous Next